Home › Drug Codes › J Codes › J7601 · OHTUVAYRE
Updated October 1st, 2026

OHTUVAYRE J Code: J7601

Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
$52.117
/ HCPCS billing unit
APC Payment Limit ?
Not published
CMS publishes none for Q4 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
HCPCS Added Date January 1, 2025
Manufacturer Merck
Route of Administration Inhalation
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Suspension

About OHTUVAYRE

Ohtuvayre is a medication aligned to the HCPCS J Code: J7601 for billing, pricing, and reimbursement purposes in the United States. Classified under Respiratory, it is administered via the inhalation route and manufactured by Merck.

According to CMS Drug Use Information: This medication is used to treat and control symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis and emphysema). Ensifentrine works by reducing the swelling of the airways and the muscles around the airways so you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath or wheezing. If sudden breathing problems occur, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
83034-0003-60 Ohtuvayre MERCK SHARP & DOHME LLC 60 3 MG / 2.5 ML
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

OHTUVAYRE Pricing & Reimbursement

J7601 Private Payer Reimbursement
$52.09 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q4 2026

OHTUVAYRE CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction or for sputum induction for diagnostic purposes.
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

OHTUVAYRE Medically Unlikely Edits (MUE)

The most billing units of J7601 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 3 mg.

Practitioner Office
2 units / day
= 6 mg per day
Hospital Outpatient
No published MUE
Outpatient hospital · OPPS

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

OHTUVAYRE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Chronic obstructive pulmonary disease (COPD)
Drug Class
Phosphodiesterase 3 Inhibitor [EPC]Phosphodiesterase 3 Inhibitors [MoA]Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitors [MoA]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available OHTUVAYRE billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for OHTUVAYRE.
What are the available OHTUVAYRE patient assistance programs?
OHTUVAYRE patient assistance information can be found through VERONA PHARMA. Visit Here →
Where can I find OHTUVAYRE prescribing information?
OHTUVAYRE prescribing information can be found at the link below. Visit Here →
Where can I find OHTUVAYRE side effect information?
OHTUVAYRE side effect information can be found through MedlinePlus at the link below.
Does billing OHTUVAYRE require JZ/JW wastage modifiers?
CMS does not include OHTUVAYRE (J7601) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J7601. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.